欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0220/001
药品名称IPV Mérieux and other NAPs
活性成分
    • inactivated type 1 polio virus 40.0 D antigen unit
    • inactivated type 2 polio virus 8.0 D antigen
    • inactivated type 3 polio virus 32.0 D antigen
剂型Suspension for injection
上市许可持有人Sanofi Pasteur MSD GmbH Paul Ehrlich Strasse 1 69181 Leimen Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • EMA (EM)
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • Austria (AT)
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Czechia (CZ)
    • Romania (RO)
    • Malta (MT)
    • Croatia (HR)
许可日期2004/02/18
最近更新日期2024/03/25
药物ATC编码
    • J07BF03 poliomyelitis, trivalent, inactivated, whole virus
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Article 4.8 Di 65/65
  • TypeLevel4:Biological: Vaccine
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase